Literature DB >> 19252911

[Sickle cell anemia in perinatal placental diagnostics].

M Oppitz1, A Klee, H-G Panitz, M Gonser, A Fisseler-Eckhoff.   

Abstract

Hereditary hemoglobinopathies should be considered as differential diagnosis when examining placental specimens for fetal growth retardation and spontaneous abortion. They can cause various macroscopic and microscopic changes in the placenta that are relevant for routine pathology examination. The importance of interdisciplinary co-operation between obstetrics and pathology to achieve optimum diagnostics and therapy planning is demonstrated using the case of a pregnant woman with heterozygous genotype and her child with homozygous genotype. Within this context, the influence of hemoglobinopathies on placental pathology and fetal development are summarized and exemplified.

Entities:  

Mesh:

Year:  2009        PMID: 19252911     DOI: 10.1007/s00292-009-1137-0

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  5 in total

1.  Images in pathology. The placenta in sickle cell disease.

Authors:  L Pantanowitz; R Schwartz; K Balogh
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

Review 2.  Sickle cell anemia in the female patient.

Authors:  Nathalie Dauphin-McKenzie; Jerry M Gilles; Elvire Jacques; Thomas Harrington
Journal:  Obstet Gynecol Surv       Date:  2006-05       Impact factor: 2.347

3.  Outcome of pregnancy in homozygous sickle cell disease.

Authors:  Graham R Serjeant; Luana Look Loy; Mark Crowther; Ian R Hambleton; Minerva Thame
Journal:  Obstet Gynecol       Date:  2004-06       Impact factor: 7.661

4.  The mechanisms of low birth weight in infants of mothers with homozygous sickle cell disease.

Authors:  Minerva Thame; Jillian Lewis; Helen Trotman; Ian Hambleton; Graham Serjeant
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

5.  DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.

Authors:  Guillaume Lettre; Vijay G Sankaran; Marcos André C Bezerra; Aderson S Araújo; Manuela Uda; Serena Sanna; Antonio Cao; David Schlessinger; Fernando F Costa; Joel N Hirschhorn; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.